Bob Holmen
Board Member
Faeth Therapeutics, Inc. (FTH)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Bob Holmen
Bob Holmen is recorded as Board Member at Faeth Therapeutics, Inc. (FTH). Faeth Therapeutics, Inc. reported in an 8-K filed June 10, 2026 that Bob Holmen was appointed director, effective June 10, 2026.
“Election of two nominees to serve as directors on the Board of Directors until the 2029 annual meeting of stockholders and until their respective successors are elected and qualified.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-06-10–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Faeth Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Anand Parikh CEO, Chairman, COO, Board Member
- John Celebi CEO, Board Member
- William Ringo Chairman, Board Member
- Brian Stephenson CFO
- Josiah Craver CFO, Chief Accounting Officer
- Christopher W. Gerry General Counsel, Board Member
- Karen Vousden, Ph.D. Board Member
- Kristian Humer Board Member
- Phillip B. Donenberg Board Member
- Saira Ramasastry Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.